PBLA

Panbela Therapeutics, Inc. Common Stock

Delisted

PBLA was delisted on the 6th of March, 2024.

11 hedge funds and large institutions have $564K invested in Panbela Therapeutics, Inc. Common Stock in 2023 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 4 increasing their positions, 1 reducing their positions, and 0 closing their positions.

Holders
11
Holders Change
+4
Holders Change %
+57.14%
% of All Funds
0.16%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
4
Increased
4
Reduced
1
Closed
Calls
Puts
Net Calls
Net Calls Change
Name Market Value Shares Shares
Change
Shares
Change %
Goldman Sachs
1
Goldman Sachs
New York
$449K 24,513 +24,513 New
HF
2
HRT Financial
New York
$34K 38,144 +38,144 New
Citadel Advisors
3
Citadel Advisors
Florida
$31.3K 34,211 -1,645 -5%
Geode Capital Management
4
Geode Capital Management
Massachusetts
$14.5K 15,886
TRCT
5
Tower Research Capital (TRC)
New York
$13.7K 15,015 +9,575 +176%
JPMorgan Chase & Co
6
JPMorgan Chase & Co
New York
$11.4K 12,451 +12,451 New
TSS
7
Two Sigma Securities
New York
$10.7K 11,689 +11,689 New
Osaic Holdings
8
Osaic Holdings
Arizona
$63 70 +68 +3,400%
Wells Fargo
9
Wells Fargo
California
$36 39 +17 +77%
Morgan Stanley
10
Morgan Stanley
New York
$18 20 +10 +100%
Bank of America
11
Bank of America
North Carolina
$2 2
CFGS
12
Concourse Financial Group Securities
Alabama